Debt-to-Equity Ratio
Updated 1928h ago
Sector Performance
67th percentileCMCSA
1.07x
Sector Median
0.73x
Sector Avg
0.09x
Deep Analysis
A company’s Debt-to-Equity Ratio (1.07x) compares its total liabilities to shareholders’ equity — a higher ratio means more debt is used to finance operations, which can amplify both returns and risk.
CMCSA’s 1.07x sits above the sector median of 0.75x, placing it in the 65th percentile among peers. Because the year-over-year and quarter-over-quarter changes are both listed as N/A, there is no observable trend to evaluate from recent data. The combination of an elevated debt level relative to the sector, with no trend to confirm improvement or deterioration, suggests a moderate risk profile — the company carries more leverage than typical peers, but the stable single data point does not signal a sudden shift. This Debt-to-Equity reading aligns with the overall NEUTRAL verdict: it is neither very high (which would be bearish) nor very low (bullish), but rather a middle ground that warrants monitoring rather than immediate action.
Frequently Asked Questions
What does the Debt-to-Equity Ratio tell investors about CMCSA?
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
How is the Debt-to-Equity Ratio calculated?
Debt-to-Equity Ratio is calculated as: Total Debt / Shareholders' Equity.
Who are CMCSA's closest peers by Debt-to-Equity Ratio?
The closest peers by Debt-to-Equity Ratio include: ETSY (-2.62x), MCK (-3.00x), TDG (-3.40x), VRSK (-3.81x), MAR (-4.04x).
The Formula
Total Debt / Shareholders' Equity
Why It Matters
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
Master CMCSA's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full CMCSA research report →CMCSA
1.07x
Sector Median
0.73x
Sector Avg
0.09x
How CMCSA's Debt-to-Equity Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.